<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04278482</url>
  </required_header>
  <id_info>
    <org_study_id>IND2018/BIO-9554</org_study_id>
    <nct_id>NCT04278482</nct_id>
  </id_info>
  <brief_title>Effects of the Consumption of a Supplement Rich in Docosahexaenoic Acid (DHA) From Algae</brief_title>
  <official_title>&quot;Diseño y Validación en Humanos de un Nuevo Complemento Alimenticio Rico en Ácido Docosahexaenoico (DHA) Procedente de Algas&quot;</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Research Council, Spain</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Comunidad de Madrid</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>National Research Council, Spain</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Vegetarian diets are increasing worldwide. To prevent nutritional deficiencies,
      supplementation with nutrients that are only present in animal food can be needed. In
      relation to fatty acids, vegetarian diets involve low intake of omega-3 polyunsaturated fatty
      acids (n-3 PUFA) and low blood levels of the long-chain n-3 derivatives, whose main dietary
      sources are fish and shellfish, particularly the levels of docosahexaenoic acid (DHA), which
      has important health benefits, are low.

      In this regard, validation of supplements rich in the n-3 fatty acid DHA that are not
      obtained from fish is needed, thus the study will test the bioavailability and metabolic
      effects of a DHA supplement form algae.

      The study will be conducted on the effects of the DHA supplement versus placebo in vegetarian
      and non-vegetarian healthy adults.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">February 10, 2020</start_date>
  <completion_date type="Anticipated">March 2021</completion_date>
  <primary_completion_date type="Anticipated">July 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Serum DHA</measure>
    <time_frame>Baseline</time_frame>
    <description>Docosahexanoic acid concentration in serum</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Serum DHA</measure>
    <time_frame>week 6</time_frame>
    <description>Docosahexanoic acid concentration in serum</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Serum DHA</measure>
    <time_frame>week 12</time_frame>
    <description>Docosahexanoic acid concentration in serum</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Serum DHA</measure>
    <time_frame>week 18</time_frame>
    <description>Docosahexanoic acid concentration in serum</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">102</enrollment>
  <condition>Vegetarian Diet</condition>
  <arm_group>
    <arm_group_label>DHA supplement</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Supplement rich in DHA form algae source</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo supplement</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Dietary supplement, DHA or Placebo</intervention_name>
    <description>Consumption of 2 capsules per day of the dietary supplement, DHA or Placebo</description>
    <arm_group_label>DHA supplement</arm_group_label>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adult (age ≥18 and ≤45 years).

          -  Healthy.

          -  Women.

          -  Men.

          -  Participant following either a vegetarian diet during at least 6 months or following a
             omnivorous diet but consuming fish 2 times per week or less.

        Exclusion Criteria:

          -  Age &lt;18 and &gt;45 years old.

          -  Pregnancy.

          -  Diseases: liver diseases, gastric diseases, irritable bowel, hypercholesterolemia,
             hypertension, diabetes, biliary colic.

          -  Having participated in a clinical study in the last 3 months.

          -  Eating disorders.

          -  Consumption of foods fortified with omega-3 fatty acids in the last 3 months.

          -  Consumption of supplements of omega-3 fatty acids in the last 3 months.

          -  Participant who have followed either a vegetarian diet for less than six months or an
             omnivorous diet including fish more than 2 times per week.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>M.Pilar Vaquero, Dr</last_name>
    <role>Principal Investigator</role>
    <affiliation>CSIC</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>M.Pilar Vaquero</name>
      <address>
        <city>Madrid</city>
        <zip>28040</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>February 18, 2020</study_first_submitted>
  <study_first_submitted_qc>February 18, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">February 20, 2020</study_first_posted>
  <last_update_submitted>March 6, 2020</last_update_submitted>
  <last_update_submitted_qc>March 6, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 9, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>National Research Council, Spain</investigator_affiliation>
    <investigator_full_name>M Pilar Vaquero</investigator_full_name>
    <investigator_title>Dr</investigator_title>
  </responsible_party>
  <keyword>Vegetarian diets</keyword>
  <keyword>Plant-based diets</keyword>
  <keyword>Vegetarians</keyword>
  <keyword>Vegans</keyword>
  <keyword>docosahexaenoic acid</keyword>
  <keyword>DHA</keyword>
  <keyword>omega-3 fatty acids</keyword>
  <keyword>algae</keyword>
  <keyword>supplementation</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

